

Show Notes 179: From Dark Matter to Digital Twins: How Concr is Revolutionising Cancer Treatment Prediction
Irina Barbina (CEO) and Matthew Griffiths (CTO) explain how Concr is using predictive modelling and digital twins to transform cancer drug development.
Feb 172 min read
